AstraZeneca to Directly List on NYSE, Maintaining UK Headquarters

Strategic Shift to New York Stock Exchange

• 📈 AstraZeneca is planning a direct listing of its shares on the New York Stock Exchange (NYSE).
• 💡 This move aims to attract a broader base of global investors.
• 📌 The company will remain listed and headquartered in London, providing relief to UK investors.

Addressing Market Concerns and Investment

• ⚠️ The decision comes after reports suggested AstraZeneca might abandon its British listing, sparking concerns about the shrinking London stock market.
• 💰 Companies are increasingly seeking higher valuations and deeper capital markets internationally.
• 🇺🇸 AstraZeneca has committed to investing $50 billion in US manufacturing by 2030.

Responding to US Market Demands

• 📉 The investment in US manufacturing is partly to avert potential tariffs on pharmaceutical imports.
• 💊 The drugmaker will also implement cuts to direct-to-patient US drug prices, as requested by the Trump administration.